Bulletin
Investor Alert

Sorrento Therapeutics Inc.

NAS: SRNE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:58 p.m.

/zigman2/quotes/205669265/composite

$

1.03

Change

+0.01 +0.98%

Volume

Volume 223,938

Quotes are delayed by 20 min

/zigman2/quotes/205669265/composite

Previous close

$ 1.02

$ 1.02

Change

0.00 0.00%

Day low

Day high

$0.98

$1.06

Open

52 week low

52 week high

$0.74

$3.60

Open

Insider Actions for Sorrento Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/21/2022 Henry H. Ji
See Remarks; Director
300   1,650
12/15/2022 Henry H. Ji
See Remarks; Director
1,500,000   Award at $0 per share. 0
12/02/2022 Henry H. Ji
See Remarks; Director
200   1,100
09/07/2022 Henry H. Ji
See Remarks; Director
88,888   Acquisition at $2.02 per share. 179,553
09/06/2022 Henry H. Ji
See Remarks; Director
55,555   Acquisition at $1.96 per share. 108,887
09/02/2022 Henry H. Ji
See Remarks; Director
2,500,000   Award at $0 per share. 0
08/26/2022 Henry H. Ji
See Remarks; Director
33,333   Acquisition at $2.11 per share. 70,332
08/25/2022 Henry H. Ji
See Remarks; Director
22,222   Acquisition at $2.06 per share. 45,777
06/14/2022 Henry H. Ji
See Remarks; Director
10,000   Acquisition at $1.4 per share. 14,000
12/27/2021 Kim D. Janda
Director
3,000   Disposition at $5.88 per share. 17,640
12/27/2021 Kim D. Janda
Director
3,000   Derivative/Non-derivative trans. at $4 per share. 12,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
3 Purchases
0 Sales
1,500,500
0
Last 6 months
8 Purchases
0 Sales
4,200,498
0
Last 12 months
9 Purchases
0 Sales
4,210,498
0

Officers and Executives

Dr. Henry H. Ji
Chairman, President & Chief Executive Officer
Dr. Shawn Sahebi
Senior Vice President-Commercial Operations
Ms. Elizabeth Adkins Czerepak
Chief Financial Officer & Executive Vice President
Dr. Robert D. Allen
Senior Vice President-Research & Development
Dr. Mike A. Royal
Chief Medical Officer
Dr. Alexis Nahama
Senior Vice President-Neurotherapeutics
Mr. William Farley
Vice President-Business Development
Ms. Tammy Reilly
Director
Dr. Kim D. Janda
Director
Mr. Jaisim Shah
Director
Mr. Brian Cooley
Senior Vice President-Corporate Communications
Dr. Mark R. Brunswick
Senior Vice President-Regulatory Affairs & Quality
Dr. Yue Wu
Independent Director
Mr. Dorman Followwill
Lead Independent Director
Mr. David Lemus
Independent Non-Executive Director
Link to MarketWatch's Slice.